George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
https://www.theatlantic.com/science/archive/2020/12/virus-mutation-catastrophe/617531/
I don't think the market gets this:
"To understand the difference between exponential and linear risks, consider an example put forth by Adam Kucharski, a professor at the London School of Hygiene & Tropical Medicine who focuses on mathematical analyses of infectious-disease outbreaks. Kucharski compares a 50 percent increase in virus lethality to a 50 percent increase in virus transmissibility. Take a virus reproduction rate of about 1.1 and an infection fatality risk of 0.8 percent and imagine 10,000 active infections—a plausible scenario for many European cities, as Kucharski notes. As things stand, with those numbers, we’d expect 129 deaths in a month. If the fatality rate increased by 50 percent, that would lead to 193 deaths. In contrast, a 50 percent increase in transmissibility would lead to a whopping 978 deaths in just one month—assuming, in both scenarios, a six-day infection-generation time."
The thing that sticks in my mind about these new early use drugs is, most of us can't be bothered to do much unless we feel proper unwell. And not wanting to shove meds down my throat at the best of times, I won't be taking drugs just in case either. I don't think I'm alone in this. The time you realise you are in a bit of trouble, it will be too late for them.
Oil read from the top of this thread.
Notice that SilverBackMerch appears to speak out of time ? "I'm sorry if I offend you, but this is ridiculous."
It looks as if SBM is connected to one of the previous posters, either Andybe or Gunto (or both).
Check it out see if you agree, I smell a rat.